Multiple Myeloma Posts on Medivizor
Navigation Menu

Multiple Myeloma Posts on Medivizor

Carfilzomib improves outcomes for previously treated multiple myeloma – a review

Posted by on Oct 19, 2017 in Multiple Myeloma | 0 comments

In a nutshell This study summarized findings on the treatment combination known as CRd (carfilzomib [Kyprolis], lenalidomide [Revlimid], and dexamethasone [Decadron]) for previously treated multiple myeloma. The study concluded that CRd is superior in improving progression and treatment response rates compared to available alternatives. Some...

Read More

Using erythropoietin mouthwash to reduce the occurrence of oral mucositis in patients receiving autologous stem cell transplantation

Posted by on Oct 7, 2017 in Multiple Myeloma | 0 comments

In a nutshell This study looked at how effective erythropoietin mouthwash was at preventing oral mucositis in cancer patients being treated with autologous stem cell transplantation. The study concluded that rinsing with erythropoietin mouthwash can prevent oral mucositis.  Some background Oral mucositis (OM) is a complication associated with...

Read More

Managing high-risk multiple myeloma

Posted by on Oct 2, 2017 in Multiple Myeloma | 0 comments

In a nutshell This study reviewed evidence on the management of high-risk multiple myeloma.  Some background Multiple myeloma is a diverse disease. Using predictors of treatment success is important to help select treatment approaches for patients. Higher risk patients may benefit from more aggressive treatment. There are multiple methods...

Read More

How anxiety, depression, and unmet patient needs impact the quality of life of patients with multiple myeloma

Posted by on Sep 26, 2017 in Multiple Myeloma | 0 comments

In a nutshell This study looked at how anxiety and depression influence the quality of life of patients with multiple myeloma. The study concluded that anxiety, depression, and unmet patient needs negatively impact the physical and emotional well-being of patients. Some background Multiple myeloma is a common type of cancer in older adults. The...

Read More

Carfilzomib versus bortezomib in multiple myeloma that has not responded to treatment

Posted by on Sep 23, 2017 in Multiple Myeloma | 0 comments

In a nutshell This paper compared the use of carfilzomib (Kyprolis) and bortezomib (Velcade) in the treatment of multiple myeloma. This study concluded that carfilzomib was associated with a reduced risk of death compared with bortezomib. Some background Multiple myeloma is a cancer of the plasma cells. New treatments have led to longer survival...

Read More

Can Video Gaming Build Resilience? You Decide…

Can Video Gaming Build Resilience?   You Decide…

Posted by on Sep 20, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke | 0 comments

In the aftermath of Hurricanes Harvey and Irma, a recent news story discussed the mental health consequences of disasters. Researcher Jean Rhodes of University of Massachusetts Boston studied the mental health of young parents living in New Orleans before and after Hurricane Katrina. RISK- Resilience In Survivors of Katrina is the project’s name. An...

Read More

Is There a Difference in Treatment in Smoldering vs. Active Myeloma?

Posted by on Sep 14, 2017 in Multiple Myeloma | 0 comments

In this Patient Power replay, an expert panel discusses the differences in treatment between smoldering and active myeloma. The expert panel includes Host Andrew Schorr, Dr. Larry Anderson, Jr. of UT Southwest Medical Center, Dr. Robert Orlowski of MD Anderson Cancer Center, and patient advocate Lynette Heniff. In this video, the panel discusses risk...

Read More